+1.800.595.1106 [email protected]

Zohydro ER becomes the first extended release hydrocodone product to be approved by the FDA. Zohydro ER is a product of Zogenix Pharmaceuticals..Read More

Fetzima ER approved by the FDA for the treatment of major depressive disorder in adults…Read More

Breo Ellipta approved by the FDA for long term maintenance of airflow obstruction in patients with COPD…Read More

ZubSolv, sublingual buprenorphine and naloxone tabs approved by the FDA for treatment of opioid addiction in combination with behavioral therapy and counseling…Read More

Gilotrif, tyrosine kinase inhibitor, approved by the FDA for treatment of metastatic non small celll lung cancer…Read More

Khedezla now approved for major depressive disorder…Read More

MIrvaso, brimonidine tartrate, now approved for recurrent rosacea…Read More

Adasuve now approved for agitation associated with schizophrenia or bipolar disorder…Read More

Tafinlar now approved for unresectable or metastatic melanoma…Read More

Mekinist approved for the treatment of unresectable or metastatic melanoma in patents with BRAF V600E or V600K mutations…Read More